a Imaging performed in newly diagnosed high-risk PCa and biochemical recurrence. b Definition of oligo-metastatic PCa by imaging. CT, computed tomography; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PCa, prostate cancer; PET, positron emission tomography; PSMA, prostate-specific membrane antigen; SPECT, single photon emission computed tomography.